Gerresheimer and Stevanato Group collaborate on the development of ready-to-use vial platform
Gerresheimer and Stevanato Group are to jointly develop a high-end Ready-To-Use (RTU) solution platform with an initial focus on vials, based on Stevanato Group’s market-leading EZ-fill technology. This collaboration is projected to help customers gain efficiencies, improve the quality standard, increase speed to market, reduce total cost of ownership and help mitigate supply chain risk.
Both companies are addressing rising demand for RTU vials in the market and the partnership serves as a market enabler to fully support customers’ evolving needs and establish a gold standard in the industrial filling process. The collaboration aims to make RTU vials a standard, available to a wide number of pharma companies globally – offering premium quality solutions to patients and reducing complexity for pharma operations.
The new solution will be available to other players in the market to standardise fill–finish operations from early phase drug development to commercialization. The new RTU solution platform from Gerresheimer and Stevanato will share the same secondary packaging, production process and sterilisation method, ensuring consistent available capacity and a reliable double sourcing to the pharmaceutical industry.
“The new developed RTU platform stands out in terms of quality, TCO and sustainability and takes the use of RTU solutions like vials and, in the future, cartridges to a new level", said Dr. Lukas Burkhardt, Member of the Management Board of Gerresheimer. "Due to the strong reduction of the particle load, the quality is significantly increased. Our new innovative solution will convince the market to significantly accelerate the conversion from bulk to RTU Vials.”
Image: Joint development of the RTU solution platform will be demonstrated at Connect in Pharma event in September.
